A study of DA-2811 for type 2 diabetes with poor blood sugar control
Part of Hormones & metabolism clinical trials.
This trial tests if adding DA-2811 to your current diabetes medications can help lower your blood sugar better. It's for people with type 2 diabetes who are already on two other diabetes drugs but still need better control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older
- You have type 2 diabetes
- Your blood sugar is not well-controlled on your current diabetes pills
- Your fasting blood sugar is 270 mg/dL or lower at screening
- Your body mass index (BMI) is between 18.5 and 40
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, DA-5218, to see if it helps control blood sugar in people with type 2 diabetes who are already taking metformin. It may offer an additional treatment option.
This study tests a new medicine (HM11260C) to see if it helps people with type 2 diabetes who are already taking metformin and dapagliflozin but still have high blood sugar. If you qualify, it could give you a new option to better control your diabetes.
This study compares different diabetes medicines to see which works best for people with type 2 diabetes who also have heart or blood vessel risks. It aims to find better treatment to protect your heart and kidneys.
This study tests an experimental tablet to see if it can help control blood sugar in people with type 2 diabetes. It may be an option for those who are already on metformin or managing with diet and exercise.
This study tests a new medicine called HP-211 in people with early-stage type 2 diabetes to see if it's safe and helps control blood sugar. You'd take the study drug along with your current diabetes management.
This early-stage study tests a new experimental drug (NNC0487-0111) designed to help regulate insulin levels in adults with type 2 diabetes. Researchers want to see if it works safely and effectively when combined with your current diabetes medications.
Hear when a new Diabete Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.